1-1 of 1
Stephen D. Gillies, MD
Close
Sort by
Journal Articles

The Novel De-Immunized Anti-CD20-IL-2 Immunocytokine DI-Leu16-IL-2 Is Effective in SCID Mice Bearing Rituximab-Resistant Human Lymphoma Xenografts.

Jan O. Staak, MD, David Colcher, PhD, Scott Lauder, Jianyi Wang, Stephen D. Gillies, MD, Andrew A. Raubitschek, MD
Journal: Blood
Blood (2004) 104 (11): 3288.
https://doi.org/10.1182/blood.V104.11.3288.3288
Published: 2004